Skip to content

Clinical trials

Phase 3 Head and Neck Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 3 Country / region: Taiwan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20131
20142
20152
20161
20172
20181
20192
20202
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Boehringer Ingelheim2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Taichung Veterans General Hospital2
Adlai Nortye Biopharma Co., Ltd.1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms19
Squamous Cell Carcinoma of Head and Neck7
Laryngeal Diseases3
Epstein-Barr Virus Infections1
Mucositis1
Nasopharyngeal Carcinoma1
Nasopharyngeal Neoplasms1
Neoplasms1
Nose Neoplasms1
Recurrence1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.